Diana Ernst, RPh

Editorial Director

Diana Ernst, RPh, is the Editorial Director for MPR, part of the Haymarket Medical Network. Since 2003, Diana has worked to provide healthcare professionals with up-to-date drug information through MPR's print and digital offerings. She is a graduate of the Ernest Mario School of Pharmacy, Rutgers University.

All articles by Diana Ernst, RPh

General Oncology

Indications Withdrawn as FDA Evaluates Several Accelerated Approvals

Diana Ernst, RPh

March 16, 2021

To prove clinical benefit, the FDA requires manufacturers to conduct confirmatory trials, also known as a phase 4 studies.

General Oncology

CDC Provides Guidance for Individuals Fully Vaccinated Against COVID-19

Diana Ernst, RPh

March 9, 2021

Fully vaccinated individuals can visit with other fully vaccinated people, or unvaccinated people from a single household who are at low risk for severe COVID-19 disease, indoors without wearing masks or physical distancing.

Skin Cancer

Cavrotolimod Designated Orphan Drug for Merkel Cell Carcinoma

Diana Ernst, RPh

March 4, 2021

Cavrotolimod is a toll-like receptor 9 agonist that is designed to induce anticancer immune responses through proprietary spherical nucleic acid (SNA™) technology.

Brain Cancer

Novel Therapy for Diffuse Intrinsic Pontine Glioma Fast Tracked

Diana Ernst, RPh

March 4, 2021

Oblato plans to evaluate OKN-007 for diffuse intrinsic pontine glioma in a phase 1/2 trial this year.

General Oncology

Janssen’s Single-Shot COVID-19 Vaccine Gets Emergency Use Authorization

Diana Ernst, RPh

March 1, 2021

The EUA was based on data from the randomized, double-blind, placebo-controlled ENSEMBLE trial.

Lung Cancer

Pirfenidone Gets Priority Review for Unclassifiable Interstitial Lung Disease

Diana Ernst, RPh

January 21, 2021

The sNDA includes data from a phase 2 trial that evaluated the efficacy and safety of pirfenidone in patients with progressive fibrosing UILD.

General Oncology

Potential Med Errors Prompt FDA Action on Vinca Alkaloid Labeling

Diana Ernst, RPh

January 19, 2021

Chemotherapy agents such as vincristine sulfate injection, vinblastine sulfate injection, and vinorelbine tartrate injection should only be prepared in IV infusion bags.

General Oncology

ACIP: COVID-19 Vaccine Should Be Offered to HCPs, LTC Residents First

Diana Ernst, RPh

December 2, 2020

The recommendation was made based on the number of confirmed COVID-19 cases among these 2 groups, as well as ethical and scientific considerations.

General Oncology

FDA Authorizes COVID-19 Test That Provides Rapid Results at Home

Diana Ernst, RPh

November 20, 2020

This is the first time the Agency has authorized a COVID-19 diagnostic test that provides rapid results at home.

General Oncology

Interim Data Show COVID-19 Vaccine Candidate mRNA-1273 Near 95% Effective

Diana Ernst, RPh

November 16, 2020

The placebo-controlled COVE study is investigating the efficacy and safety of mRNA-1273 at the 100mcg dose (given intramuscularly in a 2-dose series, approximately 28 days apart) in more than 30,000 adults aged 18 years and older.

Next post in General Oncology